Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
De Nature Indonesia is a prominent Indonesian pharmaceutical company specializing in the development and manufacture of traditional herbal medicines, commonly known as Jamu. Established in 2006 and based in Cilacap, Central Java, the company produces a diverse portfolio of natural health supplements designed to treat conditions ranging from sexually transmitted infections and hemorrhoids to chronic ailments like diabetes and cancer. The company emphasizes the use of local botanical extracts and adheres to Good Manufacturing Practices (CPOTB) as certified by the Indonesian National Agency of Drug and Food Control (BPOM). De Nature Indonesia operates a robust direct-to-consumer model, leveraging digital marketing to distribute its products across Indonesia and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on De Nature Indonesia.